You are here
The vicious circle of treatment-induced toxicities in locally advanced head and neck cancer and the impact on treatment intensity
Bossi Paolo, Cossu Rocca Maria, Corvò Renzo, Depenni Roberta, Guardamagna Vittorio, Marinangeli Franco, Miccichè Francesco, Trippa Fabio
Critical Reviews in Oncology/Hematology, Volume 116, August 2017, Pages 82–88
Dr. Paolo BossiTaste and smell alterations are so-called orphan symptoms, which Dr. Bossi defines as rare and neglected symptoms which are not assessed in classification systems and for which no effective treatment is available ...
Presentation by Dr. Joël Epstein at the TAO Congress on 8/9 December 2016 in ParisAccording to the principles of medical therapy, one anticipates that new agents having a biological effect also have side effects...
Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements
Vitaliana De Sanctis, Paolo Bossi, Giuseppe Sanguineti, Fabio Trippa, Daris Ferrari, Almalina Bacigalupo, Carla Ida Ripamonti, Michela Buglione, Stefano Pergolizzi, Johannes A. Langendjik, Barbara Murphy, Judith Raber-Durlacher, Elvio G. Russi, Rajesh V. Lalla
Critical Reviews in Oncology/Hematology, Volume 100, April 2016, Pages 147 - 166
The effects of swallowing disorders, dysgeusia, oral mucositis and xerostomia on nutritional status, oral intake and weight loss in head and neck cancer patients: A systematic review
Valentina Bressan, Simone Stevanin, Monica Bianchi, Giuseppe Aleo, Annamaria Bagnasco, Loredana Sasso
Cancer Treatment Reviews, Volume 45, April 2016, Pages 105 - 119
Veronica J. Shi, Lauren L. Levy, Jennifer N. ChoiSeminars in Oncology, Volume 43, Issue 3, June 2016, Pages 419-425
The importance of involving a gastroenterologist in oncology: GI toxicity can often be treated by doing simple GI investigations
Presentation by Dr. Jervoise Andreyev at MASCC/ISOO Annual Meeting June 23-25 2016, AdelaideProfessor Jervoise Andreyev is a Consultant Gastroenterologist in GI Consequences of Cancer Treatments at the Royal Marsden Hospital in London,...
Dosing and Safety Implications for Oncologists When Administering Everolimus to Patients With Hormone Receptor-Positive Breast Cancer
Hope S. RugoClinical Breast Cancer, Vol. 16, No. 1, 18-22
Presentation by Dr. Jean-Yves Pierga at the TAO Congress on 19/20 November 2015The first presentation of the session dedicated to “New therapies and supportive care in breast cancer” is by Dr. Jean-Yves...
Presentation by Elika Loir at the TAO Congress on 19/20 November 2015The patient, a 64-year-old woman who never smoked, is diagnosed with bronchial adenocarcinoma with EGFR mutation (Del19). The examination reveals...